Meetings

Meetings

John’s Top Recurring Meetings
Virtual meetings are easy to attend, but regular attendance at annual in-person events is the key to building your network and gaining deeper insight. My personal favorites for such in-person meetings are below. Of particular value for developers, the small meeting format of BEAM’s AMR Conference (March) and GAMRIC (September-October; formerly, the ESCMID-ASM conference series) creates excellent global networking. IDWeek (October) and ECCMID (April) are much larger meetings but also provide opportunities for networking with a substantial, focused audience via their Pipeline sessions. Hope to see you there!

  • 23-24 Mar 2027 (Basel, Switzerland): The 10th AMR Conference (3-4 Mar 2026) is now over and offered a rich program that included a 10-year retrospective (we’ve done a lot!), regulatory updates, discussions of how to pursue development in China, and much more … in addition to being a superb opportunity for networking! The program for the 2027 conference is now live; abstract submissions begin Nov 2026 and close January 15, 2027.
  • 9-13 April 2027 (Stockholm, Sweden): ESCMID Global 2027, the annual meeting of the European Society for Clinical Microbiology and Infectious Diseases. Details won’t be out for some months, but the website is here. I do know that the meeting schedule will again include a Science Policy Forum on Friday 9 April 2027 (see here the newsletter about the 2026 science policy forum) and all who are interested in Pull incentives and the antibiotic ecosystem should plan to be there!)..
  • 7-9 Sep 2027 (Bengaluru [Bangalore], India): The 3nd GAMRIC, the Global AMR Innovators Conference. Formerly the ESCMID-ASM (or ASM-ESCMID depending on location) Joint Conference on Drug Development for AMR, 2027 will be the 12th year for this series that is now under the joint sponsorship of CARB-X, ESCMID, LifeArc,GARDP, BEAM Alliance, Boston University, and AMR.Solutions. The 2026 meeting in Lisbon was superb and included substantial networking time (drinks on the lawn!), a keynote lecture by Karen Bush on the threat to beta-lactams due to the emergence of PBP3 mutations and sessions on program design for phage, development for pediatrics, and more! Check out the 2.5-minute YouTube video summary — and you can expect similar quality in 2027 in Bengaluru! Mark your calendar — details will follow in the spring of 2027.
  • 6-9 Oct 2027 (Boston, MA, USA): IDWeek 2026, the annual meeting of the Infectious Diseases Society of America, has just closed. As always, the program provided a substantial opportunity to present a product to a large audience (see also adjacent note about ESCMID) as well as opportunities to present at an IDWeek Pipeline Session. Details will follow in due course about IDWeek 2027.

  Upcoming meetings of interest to the AMR community:

  • 10-13 November 2026 (Madrid, Spain): The International Society for Infectious Diseases (ISID) has announced its 21st International Congress on Infectious Diseases (ICID). Regular registration rates for ICID 2026 are available through September 30, 2026. Register and view the preliminary program here.
  • 16-18 Nov 2026 (FAO Headquarters, Viale delle Terme di Caracalla, 00153 Rome, Italy): The 4th Annual Plenary Assembly of the AMR Multi-Stakeholder Partnership Platform, of the Quadripartite organizations (FAO, UNEP, WHO, and WOAH). “Organized ahead of the Fifth High-Level Ministerial Conference on AMR, the Plenary Assembly will bring together MSPP members and observers, partners and external stakeholders from across regions and One Health sectors. The Plenary Assembly will focus on moving from political commitments to practical delivery, with particular attention to supporting countries in implementing their AMR NAPs.” Go here for additional details to register.
  • 18-24 Nov 2026 (everywhere, but not quite all at once): World AMR Awareness Week is happening! Here are some links to active partners: WHO, US CDC, UK Government; I’m sure I’ve not found them all!
  • 23 Nov 2026 (virtual, 1-2.30p CET): WHO will host a webinar entitled: “TrACSS at 10 years: Tracking Global Progress on Antimicrobial Resistance.” TrACSS (Tracking AMR Country Self-Assessment Survey) has now being running for 10 years (!!) and this webinar will discuss its progress. Go here to register. 
  • 27-29 Jan 2027 (Las Vegas, USA): IMARI (Interdisciplinary Meeting on Antimicrobial Resistance and Innovation) sponsored by IDSA and ASM. Abstract submissions are open through 19 Aug; registration and housing will open later this summer.
  • 4 Feb 2027 (in person, Liverpool, UK): Bionow‘s Bioinfect 2027 Conference on AMR. Good networking! Go here for details and to register.
  • 9-11 Feb 2027 (virtual, 1-5p GMT each day): ACC2027 (Antimicrobial Chemotherapy Conference 2027), sponsored by GARDP and BSAC (British Society for Antimicrobial Chemotherapy) in collaboration with EUP OHAMR (European Partnership on One Health Antimicrobial Resistance). This 3-day online conference includes both symposia and poster presentations. Go here for details and to register. Note that the abstract submission deadline is 16 Nov 2026.
  • 23-24 Mar 2027 (Basel, Switzerland): The 11th AMR Conference sponsored by the BEAM Alliance. See list of Top Recurring meetings, above.
  • 9-13 April 2027 (Stockholm, Sweden): ESCMID Global 2026, the annual meeting of the European Society for Clinical Microbiology and Infectious Diseases. See Recurring Meetings list, above.
  • 27 Jun – 1 Jul 2027 (Ascona, Switzerland): NCCR-AntiResist will host the 3rd edition of its multi-day conference on antibiotic R&D. This biennial meeting has a similar structure to a Gordon Research Conference and its timing has been adjusted to be 1-year off-sync with the actual GRC (next edition of which is March 2028 — see below). Attendance requires an application; details on how to do this as well as the preliminary program are now available at the conference website. 
  • 7-9 Sep 2027 (Bangalore, India): GAMRIC  the Global AMR Innovators Conference. See list of Top Recurring meetings, above..
  • 6-9 Oct 2027 (Boston, MA, USA): IDWeek 2027. See list of Top Recurring meetings, above.
  • [Dates for 2027 are now announced] 16-24 Oct 2027 (Annecy, France, residential in-person program): ICARe (Interdisciplinary Course on Antibiotics and Resistance). This will be year 11 for this course. Patrice Courvalin orchestrates content with the support of an all-star scientific committee and faculty. The resulting soup-to-nuts training covers all aspects of antimicrobials, is very intense, and routinely gets rave reviews! Registration will open during the spring of 2027, so for now just mark your calendar with the dates and keep an eye on the course website for updates.
  • [Placeholder] ??? Mar 2028 (yes, that’s 2028, with location TBD): The 2028 Gordon Research Conference (GRC, https://www.grc.org/) entitled “Antibacterials of Tomorrow to Combat the Global Threat of Antimicrobial Resistance” and its related Gordon Research Seminar (GRS) for young doctoral and post-doctoral researchers will be sometime in March 2028. The organizers hope to coordinate dates and location with the 2028 BEAM-AMR meeting. Details to follow — mark your calendar!

Self-paced courses, online training materials, and other reference materials:

Updated on 

Share

Standardized panels of highly resistant bacteria: New resource from PACE and UKHSA

Dear All: As a way to pressure test your candidate compounds, PACE (Pathways to Antimicrobial Clinical Efficacy) and UKHSA (the UK Health Security Agency) have collaborated to release five new contemporary antimicrobial resistance (AMR) strain panels: The five panels contain 145 bacterial strains isolated within the last five years. Available organisms cover the priority Gram-negative

Updated CDC Antimicrobial Resistance Threat List (Priority Pathogen List)

Dear All: CDC have today released an update to their 2019 threat list (i.e., an update to CDC’s priority pathogen list or PPL). Here are the links you need: The webpage for the new report A PowerPoint (.pptx) summarizing all the PPLs to date The PowerPoint as a .pdf.. The AMR.Solutions webpage summarizing all the

NIAID/DMID’s 2027 BAA calls for antibacterial and antifungal therapeutics

Dear All: NIAID/DMID have released their 2027 Omnibus Broad Agency Announcement (BAA) entitled “Development of Medical Interventions for Infectious Diseases.” The key starting point is this link: https://sam.gov/workspace/contract/opp/5f75330f42ee4145990fe6a51a3dc84e/view. Much of this BAA is antiviral but Research Area 2.4 is on point for this newsletter’s audience. The call here is to “improve patient outcomes against serious

#AMRSOS: Imipenem-relebactam withdrawn from the US market

Dear All: Oh, no! Hot on the heels of the excellent talk at GAMRIC by Karen Bush in which the importance of relebactam as one of our most advanced beta-lactamase inhibitors was highlighted, we have this: Screenshot from drugs.com Yes, that’s right, Merck have notified the US FDA that imipenem-cilastatin-relebactam (RECARBIO) is being withdrawn from

Scroll to Top